European Equities Traded in the US as American Depositary Receipts Open Higher in Monday Trading

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts started the week modestly higher late Monday morning, rising 0.19% to 1,884.14 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which increased 2% and 1.5% respectively. They were followed by medical device maker EDAP TMS (FOCL) and healthcare tech company Royal Philips (PHG), which were up 1.9% and 1.3% respectively.

The decliners from continental Europe were led telecommunications company Nokia (NOK) and biopharmaceutical company DBV Technologies (DBVT), which dropped 3% and 2.8% respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and telecommunications company Ericsson (ERIC), which lost 4% and 1.7% respectively.

The gainers from the UK were led by alcoholic beverage company Diageo (DEO) and lender HSBC (HSBC), which advanced 1.3% and 1.4% respectively. They were followed by oil and gas companies Shell (SHEL) and BP (BP), which rose 1.4% and 1.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Mereo BioPharma Group (MREO) and Biodexa Pharmaceuticals (BDRX), which fell 7.6% and 8.7% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Akari Therapeutics (AKTX), which dropped 2.4% and 0.7% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10